Treatment of Stage III Non-Small Cell Lung Cancer Patients With Concurrent Chemotherapy and Radiation (70 Gy): Equivalent or Superior to 60 or 74 Gy of RTOG 0617?

MLA

Thomas J. Dilling, et al. “Treatment of Stage III Non-Small Cell Lung Cancer Patients With Concurrent Chemotherapy and Radiation (70 Gy): Equivalent or Superior to 60 or 74 Gy of RTOG 0617?” International Journal of Radiation Oncology*Biology*Physics, vol. 96, Oct. 2016, pp. E428–29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........fcd6a411381c2d6d721345b3ecd53b49&authtype=sso&custid=ns315887.

APA

Thomas J. Dilling, Bradford A. Perez, J.M. Frakes, A.O. Naghavi, & G.D. Grass. (2016). Treatment of Stage III Non-Small Cell Lung Cancer Patients With Concurrent Chemotherapy and Radiation (70 Gy): Equivalent or Superior to 60 or 74 Gy of RTOG 0617? International Journal of Radiation Oncology*Biology*Physics, 96, E428–E429.

Chicago

Thomas J. Dilling, Bradford A. Perez, J.M. Frakes, A.O. Naghavi, and G.D. Grass. 2016. “Treatment of Stage III Non-Small Cell Lung Cancer Patients With Concurrent Chemotherapy and Radiation (70 Gy): Equivalent or Superior to 60 or 74 Gy of RTOG 0617?” International Journal of Radiation Oncology*Biology*Physics 96 (October): E428–29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........fcd6a411381c2d6d721345b3ecd53b49&authtype=sso&custid=ns315887.